 |
 |
HEADLINESNIH AnnouncementsC&G AnnouncementsUCSF Courses UCSF Gains Full AAHRPP Accreditation Advance Fund Request Form and Procedures OSR Announces the Elimination of Negative Federal Disclosures NATIONAL NEWSFeds Seeking Advice on Plans for Multiple PI Policy Rights to Subject Inventions Made through Federal Funding to Foreign Entities Changes in Submission and Review of NIH SBIR and STTR Fast-Track Grant Applications Submit NIH Closeout Reports Online DHHS Issues Final Rule on Research Misconduct NSF Revises Grant Policy Manual NIH Announces Final Ethics Rules
MORE INFORMATION Provide the Office of Research by feedback by using our online form. To subscribe: email ResearchNews with the words Subscribe ResearchNews in the subject line. To unsubscribe: email to ResearchNews with the words Unsubscribe ResearchNews in the subject line. |
|
NATIONAL NEWS
Changes in Submission and Review of NIH SBIR and STTR Fast-Track Grant Applications
The NIH announced two major changes in the submission and review of Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Fast-Track grant applications.
Submission. Beginning with the December 1, 2005, submission date, you need only prepare one grant application package consisting of both Phase I and Phase II activities.
Review. Beginning with the December 1, 2005 , submission date, the option for reviewers of NIH SBIR and STTR Fast-Track applications to “decouple” the Phase I/Phase II applications at the time of review will be eliminated.
Rationale. This new policy will reduce the burden on small business applicants and reviewers by eliminating the redundant information in separate Phase I and Phase II applications.
The Phase I portion of a Fast-Track must still specify clear, measurable goals (milestones) that should be achieved prior to initiating Phase II work. In addition, as is required for all Phase II applications, the Phase II portion of a Fast-Track application must present a Commercialization Plan (maximum 15 pages) that addresses specific points.
Applicants are reminded that failure to meet their milestones will be grounds for the project not continuing into Phase II.
Reference: NIH Announcement Number NOT-OD-05 -051.
| Please direct all comments or questions to the
Office
of Research. The University of California , San Francisco Copyright 2006, The Regents of the University of California. |